相似文献
1
PLT012, a Humanized CD36-Blocking Antibody, Is Effective for Unleashing Antitumor Immunity Against Liver Cancer and Liver Metastasis.
Cancer Discov. 2025 Apr 28:OF1-OF21. doi: 10.1158/2159-8290.CD-24-1409.
2
Liensinine reshapes the immune microenvironment and enhances immunotherapy by reprogramming metabolism through the AMPK-HIF-1α axis in hepatocellular carcinoma.
J Exp Clin Cancer Res. 2025 Jul 15;44(1):208. doi: 10.1186/s13046-025-03477-6.
3
Oncolytic reovirus enhances the effect of CEA immunotherapy when combined with PD1-PDL1 inhibitor in a colorectal cancer model.
Immunotherapy. 2025 Apr;17(6):425-435. doi: 10.1080/1750743X.2025.2501926. Epub 2025 May 12.
4
Serotonin receptor 5-HT as a potential target for HCC immunotherapy.
J Immunother Cancer. 2025 Jun 23;13(6):e011088. doi: 10.1136/jitc-2024-011088.
5
Tumor-suppressing multi-enterobacteria and PD-1/PD-L1 immune checkpoint inhibitor combination improves the outcome of hepatocellular carcinoma therapy.
Front Immunol. 2025 Jun 20;16:1598436. doi: 10.3389/fimmu.2025.1598436. eCollection 2025.
6
Targeting USP47 enhances immunotherapy in hepatocellular carcinoma by destabilizing PD-L1.
Int Immunopharmacol. 2025 Aug 28;161:115024. doi: 10.1016/j.intimp.2025.115024. Epub 2025 Jun 9.
7
Nanoliposomal PD-1 antagonist target tumor-draining lymph nodes to revitalize T cells and improve anti-tumor effect in hepatocellular carcinoma.
J Nanobiotechnology. 2025 Jul 30;23(1):549. doi: 10.1186/s12951-025-03537-1.
8
CD36 Promotes Iron Accumulation and Dysfunction in CD8+ T Cells via the p38-CEBPB-TfR1 Axis in Early-stage Hepatocellular Carcinoma.
Clin Mol Hepatol. 2025 Mar 4. doi: 10.3350/cmh.2024.0948.
9
Liver fibrosis promotes immune escape in hepatocellular carcinoma via GOLM1-mediated PD-L1 upregulation.
Cancer Lett. 2021 Aug 10;513:14-25. doi: 10.1016/j.canlet.2021.05.007. Epub 2021 May 14.
10
Ganoderic acid A regulates CSF1R to reprogram tumor-associated macrophages for immune therapy of hepatocellular carcinoma.
Int Immunopharmacol. 2025 Aug 28;161:114989. doi: 10.1016/j.intimp.2025.114989. Epub 2025 Jun 7.
引用本文的文献
1
Identification of new selective CD36 inhibitors to potentiate HER2-targeted therapy in HER2-positive breast cancer.
Sci Rep. 2025 Aug 6;15(1):28709. doi: 10.1038/s41598-025-14639-z.
本文引用的文献
1
PPARβ/δ-orchestrated metabolic reprogramming supports the formation and maintenance of memory CD8 T cells.
Sci Immunol. 2024 Aug 23;9(98):eadn2717. doi: 10.1126/sciimmunol.adn2717.
2
Circulating fatty acids and risk of hepatocellular carcinoma and chronic liver disease mortality in the UK Biobank.
Nat Commun. 2024 May 2;15(1):3707. doi: 10.1038/s41467-024-47960-8.
3
Obesity-related T cell dysfunction impairs immunosurveillance and increases cancer risk.
Nat Commun. 2024 Apr 2;15(1):2835. doi: 10.1038/s41467-024-47359-5.
4
Regulatory T cell: a double-edged sword from metabolic-dysfunction-associated steatohepatitis to hepatocellular carcinoma.
EBioMedicine. 2024 Mar;101:105031. doi: 10.1016/j.ebiom.2024.105031. Epub 2024 Feb 23.
5
Fatty acid metabolism of immune cells: a new target of tumour immunotherapy.
Cell Death Discov. 2024 Jan 20;10(1):39. doi: 10.1038/s41420-024-01807-9.
6
Immunosurveillance encounters cancer metabolism.
EMBO Rep. 2024 Feb;25(2):471-488. doi: 10.1038/s44319-023-00038-w. Epub 2024 Jan 12.
7
CD36 maintains lipid homeostasis via selective uptake of monounsaturated fatty acids during matrix detachment and tumor progression.
Cell Metab. 2023 Nov 7;35(11):2060-2076.e9. doi: 10.1016/j.cmet.2023.09.012. Epub 2023 Oct 17.
8
Regulatory circuits of mitophagy restrict distinct modes of cell death during memory CD8 T cell formation.
Sci Immunol. 2023 Sep 29;8(87):eadf7579. doi: 10.1126/sciimmunol.adf7579. Epub 2023 Sep 22.
9
Extending support for mouse data in the Molecular Signatures Database (MSigDB).
Nat Methods. 2023 Nov;20(11):1619-1620. doi: 10.1038/s41592-023-02014-7.
10
Identification of pre-diagnostic lipid sets associated with liver cancer risk using untargeted lipidomics and chemical set analysis: A nested case-control study within the ATBC cohort.
Int J Cancer. 2024 Feb 1;154(3):454-464. doi: 10.1002/ijc.34726. Epub 2023 Sep 11.
Zotero 插件